Document is current
Any future updates will be listed below
-
Authors
Cao, Zhenyu
Zeng, Liyun
Wang, Zicheng
Wen, Xueyi
Zhang, Ju
-
Funding
Funding for this research was provided by:
Clinical Medical Technology Innovation Guidance Project of Hunan province (2021SK53522)
Clinical Medical Technology Innovation Guidance Project of Hunan province (2021SK53522)
Clinical Medical Technology Innovation Guidance Project of Hunan province (2021SK53522)
Clinical Medical Technology Innovation Guidance Project of Hunan province (2021SK53522)
Clinical Medical Technology Innovation Guidance Project of Hunan province (2021SK53522)
- License Information
-
More Information
Article History
Received: 23 March 2023
Revised: 12 May 2023
Accepted: 16 May 2023
First Online: 29 May 2023
Declarations
:
: The authors declare no competing interests.
: Approval to obtain experimental tissues from patients with cholangiocarcinoma and normal controls was obtained under informed consent. This study was reviewed, performed, and approved in accordance with the ethical standards as laid down in the Declaration of Helsinki by the Ethic Committee of the Second Xiangya Hospital of the Central South University ((2022) Clinical Study Review No. 095).
: The authors declare no competing interests.
